Latest Breaking News On - University of pennsylvania abramson cancer center - Page 7 : comparemela.com

Six Obstacles in Breast Cancer Detection and Treatment

At a recent conference, oncologists outlined key challenges that need to be addressed to improve breast cancer diagnosis and treatment.

Ann arborUnited statesSan antonioUniversity hospitalChristine ambrosoneAngela demicheleNadia harbeckMatthew ellisFabrice andrRegina barzilayRoswell park comprehensive cancer centerMassachusetts institute of technologyDrug administrationUniversity of north carolinaGustave roussy cancer centerSiteman cancer center

Major treatment advance revealed for adults with newly diagnosed B lineage acute lymphoblastic leukemia

Late-breaking research reveals a major treatment advance for adults with newly diagnosed B lineage acute lymphoblastic leukemia (ALL).

United statesMayo clinic in rochesterMarkr litzowSelinam lugerEmily hendersonAmerican society of hematologyUniversity of pennsylvania abramson cancer centerNational cancer instituteNational institutes of healthCancer research groupLeukemia committeeAmerican societyAnnual meetingMayo clinicAbramson cancer centerResearch group

Simplified treatment regimen results in dramatic decrease in early deaths from acute promyelocytic leukemia

The use of a simplified treatment regimen by oncologists, along with management recommendations and 24/7 support provided by a limited and dedicated group of academic disease experts, resulted in a dramatic decrease in early deaths from acute promyelocytic leukemia (APL).

United statesSelinam lugerAnandp jillellaEmily hendersonNational cancer instituteCommunity oncology research programNational institutes of healthCancer research groupCollege of georgia at augusta universityLeukemia committeeAmerican society of hematologyUniversity of pennsylvania abramson cancer centerDivision of cancer preventionGeorgia cancer centerResearch groupAmerican society

Amgen (AMGN) Says Blincyto Added To Consolidation Chemotherapy Significantly Improves Survival In Adult Patients With Measurable Residual Disease-negative B-ALL

Amgen (AMGN) Says Blincyto Added To Consolidation Chemotherapy Significantly Improves Survival In Adult Patients With Measurable Residual Disease-negative B-ALL
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSelinam lugerDavidm reeseDevelopment agreementNational cancer instituteData safety monitoring committeeNational institutes of healthPerelman school of medicineCancer research groupLeukemia committeeAmerican society of hematologyUniversity of pennsylvania abramson cancer centerResearch groupAmerican societyAnnual meetingMultichannel news release

BLINCYTO® (BLINATUMOMAB) ADDED TO CONSOLIDATION CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN ADULT PATIENTS WITH MEASURABLE RESIDUAL DISEASE-NEGATIVE B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

/PRNewswire/ Amgen (NASDAQ: AMGN) today announced the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present results from the E1910 randomized Phase 3.

Puerto ricoUnited statesMegan foxJessica akopyanSelinam lugerDavidm reeseNational cancer instituteData safety monitoring committeeHealth professional versionPerelman school of medicineAmerican society of hematologyUniversity of pennsylvania abramson cancer centerTherapeutics incEuropean unionTeneobio incKyowa kirin co ltd